8.89BMarket Cap
LossP/E TTM
Immunitybio Inc's Company Valuation
Currency: USD Updated: 2026-06-29The current valuation score of Immunitybio Inc is 9.24, ranking 41 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -10.36, which is -89.01% below the recent high of -1.14 and -179.45% above the recent low of -28.96.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.